• Phosphatase Inhibitor Cocktail 3 (100X): Lab-Proven Reliabil

  2026-06-13

  This article addresses persistent laboratory challenges in protein phosphorylation preservation, comparing strategies and solutions for robust phosphoprotein analysis. Drawing on scenario-driven Q&A, it demonstrates how Phosphatase Inhibitor Cocktail 3 (100X in DMSO) (SKU K1014) from APExBIO ensures reliable, reproducible results for cell viability and signaling pathway research.

• Safe DNA Gel Stain: Protocols, QC, and Troubleshooting Guide

  2026-06-12

  Safe DNA Gel Stain (SKU A8743) addresses the need for a high-sensitivity, less mutagenic alternative to ethidium bromide for DNA and RNA visualization in agarose and polyacrylamide gels. It is designed for research workflows prioritizing user safety and nucleic acid integrity, but is less effective for low molecular weight DNA fragments (100–200 bp) and should not be used for diagnostic or medical purposes.

• Meropenem: Mechanism, Benchmarks, and Limits in Resistance M

  2026-06-12

  Meropenem is an ultra-broad-spectrum β-lactam antibiotic carbapenem with proven efficacy against diverse Gram-negative and Gram-positive bacteria. Its mechanism targets penicillin-binding proteins, resulting in potent cell wall inhibition. Recent evidence benchmarks its activity and clarifies its limitations amid emerging carbapenem resistance.

• Patient-Derived Gastric Cancer Assembloids for Improved Drug

  2026-06-11

  This study introduces a patient-derived gastric cancer assembloid model that integrates matched tumor organoids with autologous stromal cell subpopulations, enabling more physiologically relevant drug screening and mechanistic studies. The inclusion of stromal components reveals critical tumor–stroma interactions and resistance mechanisms not captured by conventional organoid models, advancing personalized cancer research.

• Tobramycin: Optimizing Aminoglycoside Antibiotic Workflows

  2026-06-11

  Tobramycin stands out as a high-purity, water-soluble aminoglycoside antibiotic ideal for rigorous microbiology and antibiotic resistance research. This guide delivers actionable protocol setups, troubleshooting strategies, and comparative insights that empower researchers to maximize reproducibility and data clarity with APExBIO Tobramycin.

• Nicotinamide Adenine Dinucleotide (NAD+): From Redox Coenzym

  2026-06-10

  Explore the pivotal role of Nicotinamide Adenine Dinucleotide (NAD+) in linking metabolic signaling, protein deacetylation, and stress adaptation. This in-depth analysis uncovers recent breakthroughs and practical protocols, establishing new directions for advanced cellular research.

• Phosphatase Inhibitor Cocktail 3: Precision in Serine/Threon

  2026-06-10

  Phosphatase Inhibitor Cocktail 3 (100X in DMSO) delivers reliable serine/threonine phosphatase inhibition, preserving protein phosphorylation in even the most challenging lysate conditions. This APExBIO solution enables high-fidelity phosphoprotein analysis across workflows, with robust troubleshooting and proven advantages for mitochondrial signaling studies.

• Machine Learning Discovery of Senolytics: New Pathways for C

  2026-06-09

  The referenced study pioneers the use of machine learning to discover new senolytic agents, identifying ginkgetin, periplocin, and oleandrin as potent candidates. This approach demonstrates a scalable, cost-effective workflow for targeting cellular senescence, with implications for age-related disease and drug discovery.

• Targeted SPP1 Inhibition in Tumor-Associated Macrophages Red

  2026-06-09

  This study demonstrates that targeted inhibition of SPP1 in tumor-associated myeloid cells—specifically macrophages—effectively reduces tumor size in murine models. By developing a phenotypic screening strategy and a TAM-focused nanoformulation, the research identifies SPP1 as a viable therapeutic target and provides a foundation for novel anti-tumor strategies in cancer research.

• Dual PI3K–AKT–ERK Blockade to Overcome Gefitinib Resistance

  2026-06-08

  Deng et al. present a nanotechnology-enabled strategy to overcome gefitinib resistance and metastasis in lung adenocarcinoma by synergistically inhibiting the PI3K–AKT–ERK pathways. Their rationally designed co-delivery nanoplatform demonstrates efficacy in preclinical models, providing a promising translational avenue for drug-resistant NSCLC.

• Haloprogin: Broad-Spectrum Antifungal and Antimicrobial Effi

  2026-06-08

  The 1970 study by Harrison et al. established Haloprogin as a topically effective, broad-spectrum antifungal agent with unique activity against dermatophytes, Candida species, and selective Gram-positive bacteria. This foundational research provided quantitative and comparative insights into its in vitro and in vivo efficacy, informing both translational infection models and protocol development.

• Applied ddhCTP: Optimizing Antiviral Assays for RNA Virus In

  2026-06-07

  Leverage ddhCTP (3ʹ-deoxy-3′,4ʹ-didehydro-CTP) for precise, reproducible interruption of viral RNA synthesis across a spectrum of RNA viruses. This guide details protocol enhancements, advanced use-cases, and troubleshooting strategies that maximize the translational value of APExBIO’s high-purity ddhCTP for antiviral drug development and mechanistic research.

• Deferiprone in Translational Iron Stress Research: Mechanism

  2026-06-06

  This thought-leadership article positions Deferiprone (3-hydroxy-1,2-dimethylpyridin-4-one) as a transformative tool in translational research, uniting mechanistic understanding of iron-dependent cellular pathways with practical guidance on experimental design. Integrating recent metabolomics insights and APExBIO product intelligence, we offer strategic recommendations for researchers investigating cancer biology, neurovascular injury, and metabolic disease models.

• QX77: Molecular Chaperone Activator for Advanced Autophagy R

  2026-06-05

  QX77 empowers researchers to modulate chaperone-mediated autophagy with precision, offering distinct advantages for stem cell differentiation and lysosomal receptor regulation. Its robust upregulation of LAMP2A and Rab11 streamlines experimental workflows and addresses key challenges in autophagy pathway studies.

• Red Blood Cell Lysis Buffer: Elevating Osteogenic Assay Prec

  2026-06-05

  Discover how Red Blood Cell Lysis Buffer empowers precise and reproducible erythrocyte removal in osteogenic and immunological assays. This article explores advanced protocol parameters, mechanistic insights, and strategic workflow decisions to optimize blood sample preparation for high-impact research.

16312 records 1/1088 page Next 12345 下5页 Last page